NPR: Overcoming racial barriers in medical training
UC faculty member referred to as 'outspoken advocate for social justice'
Black Americans make up more than 13% of the U.S. population, yet only 5% of physicians are black.
As institutions everywhere confront the impacts of racism and inequity in their systems, medicine is not immune. Lack of access to health care isn't just a problem for Black patients, who continue to face economic, social and cultural barriers. The gaps are evident in the profession itself. Black physicians remain in a disproportionately small minority. And many African American doctors say that's because medical training itself alienates them, perpetuating those gaps which, in turn, affects the care patients receive.
Matt Smith, MD, an assistant professor of otolaryngology at UC and a pediatric otolaryngologist at Cincinnati Children's Hospital Medical Center, witnessed racial microaggressions directed toward a fellow resident-in-training in an out-of-state institution, which led to him confronting leadership.
Now, Smith is an outspoken advocate for social justice with the medical students he supervises in his role at UC. He's also starting a mentor program for minority schoolchildren, hoping to get them into medicine.
"Until there are changes made in the pipeline, all you're going to get is what you put into the system," he says.
Photo courtesy of Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.